相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Multiplex Technology Platform for the Rapid Analysis of Clinically Actionable Genetic Alterations and Validation for BRAF p.V600E Detection in 1549 Cytologic and Histologic Specimens
David L. Smith et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Gastric Cancer Prevention by Demethylation
Barbara G. Schneider et al.
CANCER PREVENTION RESEARCH (2013)
Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers
Shyhmin Huang et al.
MOLECULAR CANCER THERAPEUTICS (2013)
The future of epigenetic therapy in solid tumours-lessons from the past
Nilofer Azad et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Black Raspberry-Derived Anthocyanins Demethylate Tumor Suppressor Genes Through the Inhibition of DNMT1 and DNMT3B in Colon Cancer Cells
Li-Shu Wang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2013)
Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell Lines
Anna C. Luca et al.
PLOS ONE (2013)
Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer
Shashi Rajput et al.
PLOS ONE (2013)
Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue
Marianne Hauglid Flageng et al.
PLOS ONE (2013)
Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
Yinchen Shen et al.
PLOS ONE (2013)
Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders
Shih-Hsin Hsiao et al.
PLOS ONE (2013)
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
Metin Karahoca et al.
CLINICAL EPIGENETICS (2013)
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
Zhengzhi Zou et al.
AUTOPHAGY (2012)
Inhibition of mTOR Suppresses UVB-Induced Keratinocyte Proliferation and Survival
Theresa D. Carr et al.
CANCER PREVENTION RESEARCH (2012)
Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo
Dafeng Yang et al.
JOURNAL OF IMMUNOLOGY (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
C. Zeller et al.
ONCOGENE (2012)
XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer
Xi-Hu Yang et al.
PLOS ONE (2012)
Caspase Inhibition with XIAP as an Adjunct to AAV Vector Gene-Replacement Therapy: Improving Efficacy and Prolonging the Treatment Window
Jingyu Yao et al.
PLOS ONE (2012)
Hydrogen Sulfide Lowers Proliferation and Induces Protective Autophagy in Colon Epithelial Cells
Ya C. Wu et al.
PLOS ONE (2012)
Synergistic Effects of Nanosecond Pulsed Electric Fields Combined with Low Concentration of Gemcitabine on Human Oral Squamous Cell Carcinoma In Vitro
Jing Wang et al.
PLOS ONE (2012)
(3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo
Dong Joon Kim et al.
CANCER PREVENTION RESEARCH (2011)
Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
Xinqun Li et al.
AUTOPHAGY (2010)
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)
Pierpaolo Correale et al.
EUROPEAN JOURNAL OF CANCER (2010)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Dual targeting of EGFR and HER-2 in colon cancer cell lines
Efstathia Giannopoulou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer
Jide Wang et al.
CARCINOGENESIS (2009)
Cancer Prevention: Epigenetics Steps Up to the Plate
Jean-Pierre Issa
CANCER PREVENTION RESEARCH (2008)
mTOR and Akt signaling in cancer: SGK cycles in
Alex Toker
MOLECULAR CELL (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins
Alexei Degterev et al.
NATURE CHEMICAL BIOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Frequent alteration of XAF1 in human colorectal cancers:: Implication for tumor cell resistance to apoptotic stresses
Sun-Ku Chung et al.
GASTROENTEROLOGY (2007)
Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5
Ke Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers
Bing Zou et al.
GASTROENTEROLOGY (2006)
Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells
H. E. Jones et al.
BRITISH JOURNAL OF CANCER (2006)
Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases
Teresa Troiani et al.
MOLECULAR CANCER THERAPEUTICS (2006)
All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer
JD Wang et al.
GASTROENTEROLOGY (2006)
The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan
AH Braun et al.
ANTI-CANCER DRUGS (2005)
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
CH Yang et al.
CANCER RESEARCH (2005)
Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)
HC Dan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The relationship between hypomethylation and CpG island methylation in colorectal neoplasia
C Bariol et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Identification of XAF1 as an antagonist of XIAP anti-caspase activity
P Liston et al.
NATURE CELL BIOLOGY (2001)
Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines
WG Fong et al.
GENOMICS (2000)
分享论文
